Statement of Need n A key strategy for addressing heart disease and stroke is to educate the public and healthcare practitioners about the importance of prevention. When healthcare providers perform consistent risk factor assessments, more patients can be properly diagnosed and medically managed to prevent cardiovascular disease. Both primary and secondary prevention, as well as new developments in the diagnosis, treatment and prevention of cardiovascular disease, need to be addressed. Complementing the CVD prevention symposium are comprehensive updates on the latest advances in cardiovascular medicine. Experts will concentrate on therapeutic lifestyle intervention, lipids and lipoproteins, familial hypercholesterolemia, lipoprotein (a), residual risk, genetics for predicting CVD, hypertension, obesity, consensus and controversies in cardiometabolic health, triglycerides and CVD, PCSK9, heart health for women, insulin resistance, CHF, valvular heart disease, cardiovascular imaging, new paradigm for acute stroke management, the role of surgery and interventional cardiology and radiology for CVD health. This program is endorsed by the Southeast Lipid Association.
Location and Accommodations n Eden Roc Hotel n 4525 Collins
Avenue, Miami Beach, Florida 33140-3326 The legendary Eden Roc Hotel offers oceanfront accommodations, elegant amenities and impeccable service for the ultimate getaway. Make your hotel reservation now by calling 855-433-3676 or go to the website to receive the special group rate of $369, plus applicable taxes. Hurry! Make your reservation today. The special group rate ends Friday, January 27. To learn more about the Eden Roc Hotel, go to nobuedenroc.com.
Symposium Registration n The registration fee includes tuition, daily continental breakfast, break refreshments and lunch. To expedite registration, go to MiamiCVDPrevention.BaptistHealth.net. Confirmations will be sent for registrations received by Friday, February 3. Registrations cannot be processed or confirmed without full payment. 
Accreditation and Credits

Global Learning Objectives
n Evaluate the effects of comprehensive lifestyle changes, such as diet, exercise and education, on clinical markers that are risk factors for cardiovascular disease.
n Implement evidence-based recommendations for the medical and surgical management of obesity to improve patient outcomes.
n Apply current cholesterol-lowering therapy guidelines to reduce the risk of heart attack and stroke.
n Interpret the results and conclusions of the most relevant studies that evaluate the role of HDL as a CVD risk factor.
n Examine cardiovascular risk related to triglyceride-rich lipoproteins.
n Examine the National Lipid Association recommendations for patient-centered management of dyslipidemia.
n Identify new technologies that are being developed to further advance the minimally invasive and interventional treatment of valvular heart disease.
n Examine prevention, reversal and treatment strategies for heart failure, considering medical and surgical options.
n Demonstrate the role of atherosclerosis imaging testing in CVD risk reclassification to guide management decisions.
n Recognize the latest and emerging interventional radiology technology and procedures poised to improve the testing, diagnosis and management of cardiovascular disease.
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